Understanding how inositol triphosphate receptors work in cells
Structure and function of inositol triphosphate receptors
This study is looking at special receptors in our cells that help them respond to signals from hormones and brain chemicals, with the goal of finding new treatments for diseases like cancer and brain disorders that happen when these receptors don't work properly.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-11100747 on NIH RePORTER |
What this research studies
This research investigates inositol 1,4,5-triphosphate receptors (IP3Rs), which play a crucial role in how cells respond to various signals from hormones and neurotransmitters. By using advanced techniques like cryo-electron microscopy and X-ray crystallography, the researchers aim to uncover how these receptors function and how they can be targeted for treatment in diseases such as cancer and neurodegenerative disorders. The study will involve examining how calcium ions are released from cells and how this process affects cell behavior and health. Patients may benefit from insights gained about IP3Rs that could lead to new therapies for conditions linked to their dysfunction.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from cancer, autoimmune diseases, or neurodegenerative disorders.
Not a fit: Patients with conditions unrelated to calcium signaling or IP3R dysfunction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for cancer, autoimmune diseases, and neurodegenerative disorders.
How similar studies have performed: Other research has shown promising results in targeting calcium signaling pathways for therapeutic purposes, indicating potential success for this approach.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Karakas, Erkan — Vanderbilt University
- Study coordinator: Karakas, Erkan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.